Chestnut Hill, MA, United States of America

Jinwei Jiang

This inventor holds 2 USPTO granted patents. Top assignee: Aveo Pharmaceuticals, Inc.. Active years: 2013-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinwei Jiang. Retrieved from https://idiyas.com/inventor/jinwei-jiang-twv14j1l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jinwei Jiang: Innovator in Cancer Treatment

Introduction

Jinwei Jiang is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of monoclonal antibodies.

Latest Patents

Jiang holds 2 patents related to anti-RON antibodies. His latest patents disclose monoclonal antibodies that bind and inhibit the activation of human RON (Recepteur d'Origine Nantais). These antibodies have the potential to treat certain forms of cancer associated with the activation of RON.

Career Highlights

Jinwei Jiang is currently associated with Aveo Pharmaceuticals, Inc., where he continues to advance his research in oncology. His work focuses on developing therapeutic solutions that target specific cancer pathways.

Collaborations

Some of his notable coworkers include Kerry Whalen and Steve Bottega, who contribute to the collaborative efforts in research and development at Aveo Pharmaceuticals.

Conclusion

Jinwei Jiang's innovative work in the field of cancer treatment through the development of anti-RON antibodies showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…